Should you buy 1276.HK stock?
Last updated:
Based on market data through , StockInvest.us rates Jiangsu Hengrui Pharmaceuticals Co.,ltd (1276.HK) as Hold/Accumulate with a technical score of -0.88 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Down 1.54%
- 3-month trend forecast Down 5.94%
- High gross margin of 86.2%
- Healthy interest coverage ratio of 2,315.2x
- Lower volatility than the market (beta 0.12)
Red day on Tuesday for Jiangsu Hengrui Pharmaceuticals Co.,ltd
(Market data through Aug 11, 2026)
The Jiangsu Hengrui Pharmaceuticals Co.,ltd stock price fell by -0.604% on the last day (Tuesday, 11th Aug 2026) from HK$57.95 to HK$57.60. During the last trading day the stock fluctuated 3.41% from a day low at HK$57.25 to a day high of HK$59.20. The price has fallen in 6 of the last 10 days. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 3 million shares were bought and sold for approximately HK$174.74 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.94% during the next 3 months and, with a 90% probability hold a price between HK$46.58 and HK$61.26 at the end of this 3-month period.
1276.HK Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 9.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Jiangsu Hengrui Pharmaceuticals Co.,ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at HK$57.72. On a fall, the stock will find some support from the short-term average at HK$57.59. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Jiangsu Hengrui Pharmaceuticals Co.,ltd stock
Jiangsu Hengrui Pharmaceuticals Co.,ltd finds support from accumulated volume at HK$56.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved HK$1.95 between high and low, or 3.41%. For the last week the stock has had daily average volatility of 4.51%.
Our recommended stop-loss: HK$55.30 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 44 days ago.)
Trading Expectations (1276.HK) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Jiangsu Hengrui Pharmaceuticals Co.,ltd to open at HK$58.02, and during the day (based on 14 day Average True Range), to move between HK$56.35 and HK$58.85, which gives a possible trading interval of +/-HK$2.51 (+/-4.45%) up or down from last closing price. If Jiangsu Hengrui Pharmaceuticals Co.,ltd takes out the full calculated possible swing range there will be an estimated 4.45% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at HK$57.95 (0.61%) than the support at HK$56.60 (1.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Jiangsu Hengrui Pharmaceuticals Co.,ltd will release earnings on Monday, August 17, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.439. We will update the financials statements for Jiangsu Hengrui Pharmaceuticals Co.,ltd, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 2.34% in the first trading day after earnings release.
Is Jiangsu Hengrui Pharmaceuticals Co.,ltd stock A Buy?
Jiangsu Hengrui Pharmaceuticals Co.,ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.880
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - HK$58.02 ( 0.723%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
1276.HK Performance
Trading levels for 1276.HK
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 59.97 | 4.11% |
| R2 | 59.22 | 2.82% |
| R1 | 58.76 | 2.02% |
| Price | 57.60 | |
| S1 | 57.27 | -0.570% |
| S2 | 56.81 | -1.37% |
| S3 | 56.07 | -2.66% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 69.25 | 20.23% |
| R2 | 58.50 | 1.56% |
| R1 | 57.95 | 0.608% |
| Price | 57.60 | |
| S1 | 56.60 | -1.74% |
| S2 | 54.70 | -5.03% |
| S3 | 53.35 | -7.38% |
1276 Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Apr 29, 2026 | Apr 29, 2026 | May 27, 2026 | HK$0.228 | 0.380% |
FAQ
Click here for our free guide on how to buy Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock.
Buy 1276